SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

DMRA

Damora Therapeutics, Inc.
NASDAQHealth Care

Latest close: 18.44 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 25, 2026Reported purchase · Form 4Jennifer Jarrett, Director, President and CEO · $252.9KOpen the filing ↗
  2. Aug 10, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 6, 2026Notice of sale · Form 144Firmani Lori · Officer · $56.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record32120 flagged findings
Reported transactions (Form 4)80since Apr 17, 2023 · and 9 other holdings
Corporate events (8-K)24since Nov 23, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as GLTO.

Reverse splits in 5 years

1 reverse split in 5 years (1:25 on Aug 30, 2024) · 1:25 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 321)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 13, 26Form 3 ↗Insider transaction
  • Aug 10, 26POS AM ↗Securities offering
  • Aug 10, 2610-Q ↗Quarterly report
  • Aug 6, 26Form 144 ↗Notice of proposed sale
  • Jul 28, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.1% · event on Jun 30, 26
  • Jul 20, 268-K ↗Current report · Entered a material agreement
  • Jul 7, 26Form 4 ↗Insider transaction
  • Jun 22, 26Form 144 ↗Notice of proposed sale
  • Jun 17, 268-K ↗Current report · Shareholder vote results
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Point72 Asset Management, L.P. · 2.0% · event on Mar 31, 26 · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • May 15, 26SCHEDULE 13G ↗Passive stake · Avoro Capital Advisors LLC · 6.3% · event on Mar 31, 26
  • May 12, 2610-Q ↗Quarterly report
  • May 8, 26Form 3 ↗Insider transaction
  • May 4, 268-K ↗Current report · A senior executive left or was appointed
  • Apr 29, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 29, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 23, 26SCHEDULE 13G/A ↗Passive stake · Paramora Holding LLC · 3.4% · event on Feb 9, 26 · amendment
  • Apr 23, 26SCHEDULE 13G/A ↗Passive stake · Paragon Therapeutics, Inc. · 3.4% · event on Feb 9, 26 · amendment
  • Apr 20, 268-K ↗Current report · Auditor change filing (8-K Item 4.01)
  • Apr 1, 26Form 4 ↗Insider transaction
  • Apr 1, 26Form 3 ↗Insider transaction
  • Mar 25, 26Form 4 ↗Insider transaction

321 filings on record, the oldest from Sep 29, 20.

Listing the 25 most recent filings of the 321 on record.

8-Ks, explained

Stress2Structure9Governance13
  • Jul 20, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • May 4, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 20, 26GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Mar 23, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 11, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Feb 10, 26GovernanceA senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
  • Jan 6, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Nov 10, 25StructureEntered a material agreement+6 more in the same filing8-K 1.01 ↗
  • Oct 15, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Oct 7, 24StructureEntered a material agreement+6 more in the same filing8-K 1.01 ↗
  • Oct 2, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Sep 26, 23StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗

4 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Fairmount Funds Management LLC20.0%Feb 9, 26SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Novo Holdings A/S6.5%Sep 23, 25SCHEDULE 13D/A ↗1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • FMR LLC15.0%Nov 28, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Otto Erik7.6%Dec 31, 23SCHEDULE 13G/A ↗
  • Jain Global LLC7.5%Dec 31, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Avoro Capital Advisors LLC6.3%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Venrock Healthcare Capital Partners III, L.P.6.0%Feb 9, 26SCHEDULE 13G ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
show 5 more holdershide
  • BlackRock, Inc.5.1%Jun 30, 26SCHEDULE 13G ↗
  • Paramora Holding LLC3.4%Feb 9, 26SCHEDULE 13G/A ↗1 earlier filing
  • Paragon Therapeutics, Inc.3.4%Feb 9, 26SCHEDULE 13G/A ↗1 earlier filing
  • Point72 Asset Management, L.P.2.0%Mar 31, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Ikarian Capital, LLC0.6%Feb 28, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 6, Firmani Lori filed notice of intent to sell up to $56K.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+1 more recent notices

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 25, 26Buy$253KJennifer JarrettDirector, President and CEO↗
  • Jul 6, 26Sell$7KGarrett WinslowGeneral Counsel↗
  • Jan 2, 26Sell$3KLori FirmaniChief Financial Officer↗
  • Jan 2, 26Sell$5KGarrett WinslowGeneral Counsel↗
  • Jan 2, 26Sell$15KHans T. SchambyeChief Executive Officer↗
  • Jul 3, 25Sell$498Lori FirmaniInterim CFO↗
  • Jul 3, 25Sell$881Garrett WinslowGeneral Counsel↗
  • Jul 3, 25Sell$2KHans T. SchambyeChief Executive Officer↗
  • Jan 3, 25Sell$8KHans T. SchambyeChief Executive Officer↗
  • Jan 3, 25Sell$1KLori FirmaniInterim CFO↗
  • Jan 3, 25Sell$3KGarrett WinslowGeneral Counsel↗
  • Aug 15, 23Sell$29KORBIMED ADVISORS LLC↗

There are 12 more transactions in this stretch.

Stock compensation, tax and giftsshow the 16 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jul 3, 26Compensationamount n/aGarrett WinslowGeneral Counsel↗
  • Mar 30, 26Compensationamount n/aJennifer JarrettSee Remarks↗
  • Feb 9, 26Compensationamount n/aFairmount Funds Management LLC↗
  • Feb 9, 26Compensationamount n/aFairmount Funds Management LLC↗
  • Feb 9, 26Compensationamount n/aJulianne Bruno↗
  • Jan 5, 26Compensationamount n/aL. Becker HewesChief Medical Officer↗
  • Jan 5, 26Compensationamount n/aSherwin SattarzadehChief Operating Officer↗
  • Jan 2, 26Compensationamount n/aLori FirmaniChief Financial Officer↗
  • Jan 2, 26Compensationamount n/aGarrett WinslowGeneral Counsel↗
  • Jan 2, 26Compensationamount n/aHans T. SchambyeChief Executive Officer↗
  • Jul 3, 25Compensationamount n/aLori FirmaniInterim CFO↗
  • Jul 3, 25Compensationamount n/aGarrett WinslowGeneral Counsel↗
  • Jul 3, 25Compensationamount n/aHans T. SchambyeChief Executive Officer↗
  • Jan 3, 25Compensationamount n/aHans T. SchambyeChief Executive Officer↗
  • Jan 3, 25Compensationamount n/aLori FirmaniInterim CFO↗
  • Jan 3, 25Compensationamount n/aGarrett WinslowGeneral Counsel↗

The full record holds 63 transactions and goes back to Jan 4, 23.

Its sector and its market

Damora Therapeutics, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Damora Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Damora Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
321 documents on file, from Sep 29, 2020 to Sep 28, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.